Deluccia Robert J - Dec 2, 2021 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Signature
/s/ Robert J. DeLuccia
Stock symbol
ACXP
Transactions as of
Dec 2, 2021
Transactions value $
$70,066
Form type
4
Date filed
1/4/2024, 04:26 PM
Previous filing
Nov 22, 2021
Next filing
Jul 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACXP Common Stock Gift $0 -40K -3.81% $0.00 1.01M Dec 2, 2021 Direct F1
transaction ACXP Common Stock Gift $0 -40K -3.96% $0.00 971K Dec 12, 2023 Direct F1
transaction ACXP Common Stock Gift $0 -30K -3.09% $0.00 941K Dec 22, 2023 Direct F1
transaction ACXP Common Stock Options Exercise $70.1K +19.7K +2.1% $3.55 961K Jan 3, 2024 Direct
holding ACXP Common Stock 3.85K Dec 2, 2021 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACXP Warrants for Common Stock Options Exercise $0 -19.7K -100% $0.00* 0 Jan 3, 2024 Common Stock 19.7K $3.55 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These transactions involved bona fide gifts by the Reporting Person of an aggregate of 110,000 shares of the Issuer's common stock to certain of the Reporting Person's family members who do not share the Reporting Person's household. The Reporting Person disclaims beneficial ownership of the securities held by such family members, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. These transactions are late due to an inadvertent administrative error and not any error of the Reporting Person.